{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:26:13Z","timestamp":1788870373897,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003752","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT100100835"],"award-info":[{"award-number":["FT100100835"]}],"id":[{"id":"10.13039\/501100003752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003752","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DE140100588"],"award-info":[{"award-number":["DE140100588"]}],"id":[{"id":"10.13039\/501100003752","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Victorian Government's Operational Infrastructure Support"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.pbb.2014.10.004","type":"journal-article","created":{"date-parts":[[2014,10,12]],"date-time":"2014-10-12T10:18:44Z","timestamp":1413109124000},"page":"15-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington's disease"],"prefix":"10.1016","volume":"127","author":[{"given":"Thibault","family":"Renoir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Argyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Chevarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lanfumey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-8922","authenticated-orcid":false,"given":"Anthony J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2014.10.004_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jad.2012.03.007","article-title":"Greater striatal dopamine transporter density may be associated with major depressive episode","volume":"141","author":"Amsterdam","year":"2012","journal-title":"J Affect Disord"},{"issue":"Pt 12","key":"10.1016\/j.pbb.2014.10.004_bb0010","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington's disease progression.PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.pbb.2014.10.004_bb0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/NEN.0b013e3181ea167f","article-title":"Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease","volume":"69","author":"Benn","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pbb.2014.10.004_bb0020","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2014.10.004_bb0025","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic\u2013pituitary\u2013adrenal axis in the R6\/2 transgenic mouse model of Huntington's disease","volume":"15","author":"Bjorkqvist","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pbb.2014.10.004_bb0030","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","article-title":"Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males","volume":"17","author":"Bode","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pbb.2014.10.004_bb0035","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2014.10.004_bb0040","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pbb.2014.10.004_bb0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000322540","article-title":"Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation","volume":"8","author":"Dallerac","year":"2011","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.pbb.2014.10.004_bb0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","article-title":"Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease","volume":"163","author":"Dowie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2014.10.004_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pnpbp.2008.11.012","article-title":"Sex differences in corticolimbic dopamine and serotonin systems in the rat and the effect of postnatal handling","volume":"33","author":"Duchesne","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.pbb.2014.10.004_bb0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.pbb.2014.10.004_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2014.10.004_bb0070","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2014.10.004_bb0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pscychresns.2012.06.004","article-title":"The interaction between dopamine transporter function, gender differences, and possible laterality in depression","volume":"211","author":"Hsiao","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pbb.2014.10.004_bb0080","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington's disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2014.10.004_bb0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/gbb.12041","article-title":"Mice lacking the Parkinson's related GPR37\/PAEL receptor show non-motor behavioral phenotypes: age and gender effect","volume":"12","author":"Mandillo","year":"2013","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pbb.2014.10.004_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2014.05.004","article-title":"High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice","volume":"69","author":"Mo","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pbb.2014.10.004_bb0095","doi-asserted-by":"crossref","first-page":"e18336","DOI":"10.1371\/journal.pone.0018336","article-title":"Altered dopamine and serotonin metabolism in motorically asymptomatic R6\/2 mice","volume":"6","author":"Mochel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2014.10.004_bb0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2011.01.036","article-title":"Impaired dopamine release and uptake in R6\/1 Huntington's disease model mice","volume":"492","author":"Ortiz","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2014.10.004_bb0105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2012.02.042","article-title":"Motor function and dopamine release measurements in transgenic Huntington's disease model rats","volume":"1450","author":"Ortiz","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2014.10.004_bb0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.11.063","article-title":"Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation","volume":"507","author":"Orvoen","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2014.10.004_bb0115","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddn385","article-title":"Altered serotonin receptor expression is associated with depression-related behavior in the R6\/1 transgenic mouse model of Huntington's disease","volume":"18","author":"Pang","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pbb.2014.10.004_bb0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2009.10.015","article-title":"Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers","volume":"37","author":"Pavese","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pbb.2014.10.004_bb0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/nbdi.2002.0534","article-title":"Evidence for dysfunction of the nigrostriatal pathway in the R6\/1 line of transgenic Huntington's disease mice","volume":"11","author":"Petersen","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pbb.2014.10.004_bb0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fnbeh.2014.00135","article-title":"Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms","volume":"8","author":"Pla","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.pbb.2014.10.004_bb0140","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pbb.2014.10.004_bb0135","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington's disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pbb.2014.10.004_bb0150","doi-asserted-by":"crossref","first-page":"e22133","DOI":"10.1371\/journal.pone.0022133","article-title":"Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression","volume":"6","author":"Renoir","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2014.10.004_bb0145","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1476-5381.2011.01567.x","article-title":"Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise","volume":"165","author":"Renoir","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2014.10.004_bb0155","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1046\/j.1471-4159.1999.721773.x","article-title":"Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation","volume":"72","author":"Reynolds","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2014.10.004_bb0160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0169-328X(02)00216-4","article-title":"Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease","volume":"102","author":"Spektor","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pbb.2014.10.004_bb0165","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.pbb.2014.10.004_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(97)00450-3","article-title":"Modulation of mesolimbic dopaminergic activity over the rat estrous cycle","volume":"229","author":"Thompson","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2014.10.004_bb0175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1037\/a0024053","article-title":"Psychomotor stimulation by dopamine D(1)-like but not D(2)-like agonists in most mouse strains","volume":"19","author":"Thomsen","year":"2011","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.10.004_bb0180","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","article-title":"Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)","volume":"85","author":"van Duijn","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pbb.2014.10.004_bb0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00213-012-2860-4","article-title":"Sex differences in novelty- and psychostimulant-induced behaviors of C57BL\/6 mice","volume":"225","author":"Van Swearingen","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2014.10.004_bb0190","first-page":"227","article-title":"Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease","volume":"46","author":"Weintraub","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pbb.2014.10.004_bb0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molbrainres.2003.08.009","article-title":"Analysis of cellular, transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology","volume":"119","author":"Yohrling","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pbb.2014.10.004_bb0200","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s007020070084","article-title":"Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice","volume":"107","author":"Yu","year":"2000","journal-title":"J Neural Transm"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714002780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714002780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T12:20:04Z","timestamp":1538137204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305714002780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":40,"alternative-id":["S0091305714002780"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2014.10.004","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2014.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}